Transanal minimally invasive surgery for rectal cancer

Area of Science:

• Colorectal Surgery
• Surgical Oncology
• Minimally Invasive Procedures

Background:

• Increased rectal cancer screening and chemoradiotherapy response rates lead to more treatable early-stage cancers.
• Growing interest in organ preservation strategies to minimize proctectomy morbidity.
• Transanal minimally invasive surgery (TAMIS) emerges as a viable local excision platform.

Purpose of the Study:

• To review recent advancements in TAMIS for rectal cancer treatment.
• To highlight the current role and oncological safety of TAMIS.
• To discuss TAMIS as an alternative to proctectomy in selected cases.

Main Methods:

• Review of current literature on TAMIS in rectal cancer management.
• Analysis of oncological outcomes and cost-effectiveness of TAMIS.
• Evaluation of TAMIS as a platform for local excision using laparoscopic instruments.

Main Results:

• TAMIS provides an oncologically safe method for local excision of rectal tumors.
• The technique is cost-effective and utilizes standard laparoscopic instruments.
• TAMIS facilitates organ preservation in selected rectal cancer patients.

Conclusions:

• TAMIS is an evolving and important minimally invasive surgical option for selected rectal cancers.
• It offers a valuable alternative to proctectomy, potentially reducing associated morbidity.
• Further research and adoption of TAMIS can enhance rectal cancer treatment paradigms.